跳至主要内容
临床试验/JPRN-UMIN000008109
JPRN-UMIN000008109已完成未知

Oral administration of diclofenac in the prevention of post-ERCP pancreatitis: A double-blind, multicenter study. - DBT of diclofenac in the prevention of post-ERCP pancreatitis.

The 4th department of internal medicine, Sapporo Medical University0 个研究点目标入组 430 人开始时间: 2012年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
430

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with hypersensitivity to diclofenac. 2) Patients with performance status 4. 3) Patients who are treated with diclofenac or received diclofenac within a week. 4) Patients with a history of EST and EPBD. 5) Patients with Vater tumor 6) Patients with divism 7) Patients with chronic pancreatitis 8) Patients with biliary pancreatitis 9) Patients who are judged inappropriate by chief (responsive) medical examiner.

研究者

发起方
The 4th department of internal medicine, Sapporo Medical University

相似试验